References
- 1. O. Ojo, Dietary intake and type 2 diabetes, Nutrients 11(9) (2019) Article ID 2177; https://doi.org/10.3390/nu11092177676966431514301
- 2. R. E. Perez-Morales, M. D. Del Pino, J. M. Valdivielso, A. Ortiz, C. Mora-Fernandez and J. F. Navarro-Gonzalez, Inflammation in diabetic kidney disease, Nephron 143(1) (2019) 12–16; https://doi.org/10.1159/00049327830273931
- 3. E. Rendra, V. Riabov, D. M. Mossel, T. Sevastyanova, M. C. Harmsen and J. Kzhyshkowska, Reactive oxygen species (ROS) in macrophage activation and function in diabetes, Immunobiology 224(2) (2019) 242–253; https://doi:10.1016/j.imbio.2018.11.01010.1016/j.imbio.2018.11.01030739804
- 4. T. V. Rohm, D. T. Meier, J. M. Olefsky and M. Y. Donath, Inflammation in obesity, diabetes, and related disorders, Immunity 55(1) (2022) 31–55; https://doi.org/10.1016/j.immuni.2021.12.013877345735021057
- 5. J. James, Dying well with diabetes, Ann. Palliat. Med. 8(2) (2019) 178–189; https://doi.org/10.21037/apm.2018.12.1030691282
- 6. E. Niccolai, S. Baldi, F. Ricci, E. Russo, G. Nannini, M. Menicatti, G. Poli, A. Taddei, G. Bartolucci, A. S. Calabro, F. C. Stingo and A. Amedei, Evaluation and comparison of short chain fatty acids composition in gut diseases, World J. Gastroenterol. 25(36) (2019) 5543–5558; https://doi.org/10.3748/wjg.v25.i36.5543676798331576099
- 7. P. Markowiak-Kopec and K. Slizewska, The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome, Nutrients 12(4) (2020) Article ID 1107; https://doi.org/10.3390/nu12041107723097332316181
- 8. J. Frampton, K. G. Murphy, G. Frost and E. S. Chambers, Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function, Nat. Metab. 2 (2020) 840–848; https://doi.org/10.1038/s42255-020-0188-732694821
- 9. F. Wang, H. Wu, M. Fan, R. Yu, Y. Zhang, J. Liu, X. Zhou, Y. Cai, S. Huang, Z. Hu and X. Jin, Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human bladder cancer cells, FASEB J. 34(3) (2020) 4266–4282; https://doi.org/10.1096/fj.201902626R31957111
- 10. W. Ratajczak, A. Ryl, A. Mizerski, K. Walczakiewicz, O. Sipak and M. Laszczynska, Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs), Acta Biochim. Pol. 66(1) (2019) 1–12; https://doi.org/10.18388/abp.2018_264830831575
- 11. W. Xia, X. Dai, L. K. Ding, Y. Xi, M. Yan, C. X. Yi and H. X. Xu, Three main short-chain fatty acids inhibit the activation of THP-1 cells by Mycoplasma pneumoniae, Biosci. Biotechnol. Biochem. 85(4) (2021) 923–930; https://doi.org/10.1093/bbb/zbaa11033590852
- 12. M. Wang, L. Song, C. Strange, X. Dong and H. Wang, Therapeutic effects of adipose stem cells from diabetic mice for the treatment of type 2 diabetes, Mol. Ther. 26(8) (2018) 1921–1930; https://doi.org/10.1016/j.ymthe.2018.06.013609439130005867
- 13. W. Huang, Y. Man, C. Gao, L. Zhou, J. Gu, H. Xu, Q. Wan, Y. Long, L.Chai, Y. Xu and Y. Xu, Short-chain fatty acids ameliorate diabetic nephropathy via GPR43-mediated inhibition of oxidative stress and NF-κB signaling, Oxid. Med. Cell. Longev. 2020 (2020) Article ID 4074832 (21 pages); https://doi.org/10.1155/2020/4074832742206832831998
- 14. L. Yuan, Y. Zhu, S. Huang, L. Lin, X. Jiang and S. Chen, NF-kappaB/ROS and ERK pathways regulate NLRP3 inflammasome activation in Listeria monocytogenes infected BV2 microglia cells, J. Microbiol. 59 (2021) 771–781; https://doi.org/10.1007/s12275-021-0692-934061343
- 15. J. Zou, Y. Zhang, J. Sun, X. Wang, H. Tu, S. Geng, R. Liu, Y. Chen and Z. Bi, Deoxyelephantopin induces reactive oxygen species-mediated apoptosis and autophagy in human osteosarcoma cells, Cell. Physiol. Biochem. 42(5) (2017) 1812–1821; https://doi.org/10.1159/00047953728750364
- 16. X. Shen, X. Jiang, L. Qian, A. Zhang, F. Zuo and D. Zhang, Polyphenol extracts from germinated mung beans can improve Type 2 diabetes in mice by regulating intestinal microflora and inhibiting inflammation, Front. Nutr. 9 (2022) Article ID 846409 (13 pages); https://doi.org/10.3389/fnut.2022.846409898868135399678
- 17. X. Cui, D. W. Qian, S. Jiang, E. X. Shang, Z. H. Zhu and J. A. Duan, Scutellariae radix and Coptidis rhizoma improve glucose and lipid metabolism in T2DM rats via regulation of the metabolic profiling and MAPK/PI3K/Akt signaling pathway, Int. J. Mol. Sci. 19(11) (2018) Article ID 3634 (22 pages); https://doi.org/10.3390/ijms19113634627495030453687
- 18. S. Ding, S. Xu, Y. Ma, G. Liu, H. Jang and J. Fang, Modulatory mechanisms of the NLRP3 inflammasomes in diabetes, Biomolecules 9(12) (2019) Article ID 850 (15 pages); https://doi:10.3390/biom912085010.3390/biom9120850699552331835423
- 19. F. Yang, Y. Qin, Y. Wang, S. Meng, H. Xian, H. Che, J. Lv, Y. Li, Y. Yu, Y. Bai and L. Wang, Metformin inhibits the NLRP3 inflammasome via AMPK/mTOR-dependent effects in diabetic cardiomyopathy, Int. J. Biol. Sci. 15(5) (2019) 1010–1019; https://doi:10.7150/ijbs.2968010.7150/ijbs.29680653578131182921
- 20. X. Chen, D. Zhang, Y. Li, W. Wang, W. Bei and J. Guo, NLRP3 inflammasome and IL-1β pathway in type 2 diabetes and atherosclerosis: Friend or foe?, Pharmacol. Res. 173 (2021) Article ID 105885; https://doi:10.1016/j.phrs.2021.10588510.1016/j.phrs.2021.10588534536551
- 21. X. Wang, G. He, Y. Peng, W. Zhong, Y. Wang and B. Zhang, Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway, Sci. Rep. 5 (2015) Article ID 12676 (10 pages); https://doi:10.1038/srep1267610.1038/srep12676452265426234821
- 22. C. D. Gonzalez, M. S. Lee, P. Marchetti, M. Pietropaolo, R. Towns, M. I. Vaccaro, H. Watada and J. W. Wiley, The emerging role of autophagy in the pathophysiology of diabetes mellitus, Autophagy 7(1) (2011) 2–11; https://doi.org/10.4161/auto.7.1.13044335948120935516
- 23. T. Tao and H. Xu, Autophagy and obesity and diabetes, Adv. Exp. Med. Biol. 1 (2020) 445–461; https://doi.org/10.1007/978-981-15-4272-5_3232671767
- 24. B. Cui, H. Lin, J. Yu, J. Yu and Z. Hu, Autophagy and the immune response, Adv. Exp. Med. Biol. 1206 (2019) 595–634; https://doi.org/10.1007/978-981-15-0602-4_27712036331777004
- 25. Y. Yuan, Y. Chen, T. Peng, L. Li, W. Zhu, F. Liu, S. Liu, X. An, R. Luo, J. Cheng, J. Lu, Mitochondrial ROS-induced lysosomal dysfunction impairs autophagic flux and contributes to M1 macrophage polarization in a diabetic condition, Clin. Sci. (Lond). 133(15) (2019) 1759–1777; https://doi.org/10.1042/CS2019067231383716
- 26. R. Wu, X. Liu, J. Yin, H. Wu, X. Cai, N. Wang, Y. Qian and F. Wang, IL-6 receptor blockade ameliorates diabetic nephropathy via inhibiting inflammasome in mice, Metabolism 83 (2018) 18–24; https://doi.org/10.1016/j.metabol.2018.01.00229336982
- 27. W. Ying, W. Fu, Y. S. Lee, J. M. Olefsky, The role of macrophages in obesity-associated islet inflammation and β-cell abnormalities, Nat. Rev. Endocrinol. 16(2) (2020) 81–90; https://doi:10.1038/s41574-019-0286-310.1038/s41574-019-0286-3831527331836875